Marathon Patent Group's Subsidiary, Selene Communication Technologies, LLC, Licenses Reed Elsevier Inc.Share this:
LOS ANGELES, CA -- (Marketwired) -- 08/20/15 -- Marathon Patent Group, Inc. (NASDAQ: MARA) ("Marathon"), a patent licensing company, announced today that Reed Elsevier has taken a license to Marathon subsidiary Selene Communication Technologies, LLC's, ("Selene") portfolio. The consideration to be paid by Reed Elsevier Inc. to Selene and all other terms of the agreement are confidential.
The Selene portfolio relates to intrusion detection services, tools for intelligent searches applied to data management systems, as well as global information networks like the Internet, and architectures for efficiently locating desired resources in a network. The portfolio includes U.S. patent number 6,363,377, entitled "Search Data Processor," U.S. patent number 7,143,444, entitled "Application-Layer Anomaly and Misuse Detection," and U.S. patent number 7,177,867, entitled "Method and Apparatus for Providing Scalable Resource Discovery." The '444 Patent is currently being asserted against Fluke Electronics Corporation in the United States District Court for the District of Delaware and Trend Micro Inc., in the United States District Court for the Northern District of California. Mishcon de Reya New York LLP is representing Selene in these actions.
About Marathon Patent Group:
Marathon is a patent acquisition and monetization company. The Company acquires patents from a wide-range of patent holders from individual inventors to Fortune 500 companies. Marathon's strategy of acquiring patents that cover a wide-range of subject matter allows the Company to achieve diversity within its patent asset portfolio. Marathon generates revenue with its diversified portfolio through actively managed concurrent patent rights enforcement campaigns. This approach is expected to result in a long-term, diversified revenue stream. To learn more about Marathon Patent Group, visit www.marathonpg.com.
Safe Harbor Statement
Certain statements in this press release constitute "forward-looking statements" within the meaning of the federal securities laws. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), not limited to Risk Factors relating to its patent business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.
Marathon Patent Group
Source: Marathon Patent Group
Released August 20, 2015Share this: